Archive | Cardiothoracic

Mixed Dyslipidaemia in Metabolic Syndrome Patients

The concept of the metabolic syndrome is at least 80 years old and has always been viewed as a constellation of metabolic disturbances, all of which are recognized risk factors for cardiovascular disease (CVD). The metabolic syndrome has been called a master of disguise as it can present in many ways according to the different […]

Continue Reading · 0

OA and RA – Cardiovascular treatment outcomes

A recent study measured cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis (OA) and rheumatoid arthritis (RA) in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. The MEDAL programme’s primary objective was to compare thrombotic cardiovascular events with etoricoxib and diclofenac during the long-term treatment of patients with osteoarthritis […]

Continue Reading · 0